odad4 Antibody

What is ODAD4 and what is its biological significance?

ODAD4 (outer dynein arm docking complex subunit 4) is a protein encoded by the ODAD4 gene, with the canonical human protein consisting of 672 amino acid residues and a molecular weight of 76.7 kDa. It functions as a critical component of the outer dynein arm-docking complex (ODA-DC) that mediates the binding of outer dynein arms (ODAs) onto doublet microtubules in motile cilia .

This protein is primarily expressed in ciliated tissues, notably the nasal mucosa, and plays an essential role in ciliary function. ODAD4 is also known by several other names in the literature, including tetratricopeptide repeat domain 25 (TTC25), tetratricopeptide repeat protein 25, and TPR repeat protein 25 . Mutations in the ODAD4 gene have been implicated in Primary Ciliary Dyskinesia (PCD), a genetic disorder characterized by defects in motile cilia that can lead to chronic respiratory issues and other symptoms .

What are the optimal experimental applications for ODAD4 antibodies?

ODAD4 antibodies are valuable tools for multiple experimental applications in ciliary research. Based on currently available commercial antibodies, the most reliable applications include:

• Western blot (WB): For detecting ODAD4 protein expression levels and confirming antibody specificity

• Immunohistochemistry on paraffin-embedded sections (IHC-p): For examining ODAD4 localization in tissue samples

• Immunofluorescence (IF): For visualizing subcellular localization in ciliated cells

• Flow cytometry (FCM): For quantitative analysis of ODAD4 expression in cell populations

When selecting an ODAD4 antibody for your research, consider the specific application and host species reactivity. Currently available antibodies demonstrate reactivity with human (Hu), mouse (Ms), and rat (Rt) ODAD4 proteins, making cross-species studies feasible with the same antibody preparation .

What tissue samples are optimal for ODAD4 expression studies?

For studying ODAD4 expression patterns, the following tissues and sample types are recommended:

• Respiratory epithelium: Particularly nasal mucosa, trachea, and bronchial samples where ODAD4 is predominantly expressed in the ciliated epithelial cells

• Embryonic nodal tissues: For developmental studies on left-right asymmetry determination

• Reproductive tissues: Including fallopian tubes in females and testes in males, which contain motile cilia structures

When preparing tissue samples for immunohistochemistry, a 10% neutral-buffered formalin fixation followed by standard paraffin embedding typically preserves ODAD4 antigenicity. Heat-induced epitope retrieval in citrate buffer (pH 6.0) is generally recommended for optimal antibody binding.

What is known about the structural domains of ODAD4 and their functions?

ODAD4 contains tetratricopeptide repeat (TPR) domains that are crucial for protein-protein interactions within the ciliary machinery. The protein structure includes:

• TPR domains: Mediate interactions with other ODA-DC components

• C-terminal region: Contains key functional motifs for ciliary localization

• N-terminal region: Involved in protein stability and regulation

When designing experiments targeting specific domains, consider using antibodies directed against the C-terminal region, as this region contains distinctive epitopes that differentiate ODAD4 from other TPR-containing proteins . For domain-specific studies, combining antibodies targeting different regions can provide complementary data on protein interactions and modifications.

How does ODAD4 interact with other ciliary proteins?

ODAD4 functions as part of the outer dynein arm docking complex (ODA-DC), which serves as a platform for attaching outer dynein arms to the microtubule doublets in motile cilia. Key interaction partners include:

• Other ODA-DC components: Forms a stable complex with additional docking proteins

• Outer dynein arm proteins: Facilitates their proper assembly and attachment

• Microtubule-associated proteins: Enables correct positioning along the axoneme

For studying these interactions, co-immunoprecipitation experiments using ODAD4 antibodies under native conditions (non-denaturing buffers such as RIPA without SDS) are recommended. Consider crosslinking approaches to stabilize transient interactions, using formaldehyde (0.5-1%) or specialized crosslinkers with cleavable spacer arms for subsequent complex analysis.

What are the optimal conditions for Western blot analysis using ODAD4 antibodies?

For successful Western blot detection of ODAD4 protein, the following protocol modifications are recommended:

• Sample preparation:

  • Use RIPA buffer supplemented with protease inhibitors

  • Include phosphatase inhibitors when studying phosphorylation status

  • Heat samples at 95°C for 5 minutes in standard Laemmli buffer

• Gel electrophoresis:

  • 8-10% SDS-PAGE gel provides optimal resolution for the 76.7 kDa ODAD4 protein

  • Load 20-50 μg of total protein per lane for standard detection

• Transfer and detection:

  • Semi-dry transfer: 25V for 30 minutes or wet transfer: 100V for 1 hour

  • Blocking: 5% non-fat milk in TBST for 1 hour at room temperature

  • Primary antibody: Dilute according to manufacturer's recommendations (typically 1:500-1:2000) and incubate overnight at 4°C

  • Detection systems: HRP-conjugated antibodies are available for direct detection without secondary antibody steps

Expected results: A distinct band at approximately 77 kDa, with possible additional bands corresponding to known isoforms resulting from alternative splicing .

What controls should be included when validating ODAD4 antibody specificity?

Proper validation of ODAD4 antibodies requires the following controls:

• Positive controls:

  • Ciliated tissue lysates (nasal epithelium, trachea)

  • Recombinant ODAD4 protein (full-length or fragment)

• Negative controls:

  • Non-ciliated tissue lysates (e.g., liver)

  • Peptide competition assay: Pre-incubation of antibody with immunizing peptide should abolish specific signal

  • ODAD4 knockout or knockdown samples (if available)

• Specificity controls:

  • Comparison of staining patterns with a second antibody against a different ODAD4 epitope

  • Comparison with mRNA expression data from RT-PCR or RNA-seq

Document both specific and non-specific binding to provide complete validation data for your research publications.

How can ODAD4 antibodies be used to investigate Primary Ciliary Dyskinesia (PCD)?

ODAD4 antibodies offer valuable tools for PCD research through several methodological approaches:

• Diagnostic immunostaining:

  • Analyze ODAD4 localization in patient ciliated epithelial cells

  • Compare with healthy controls to identify mislocalization patterns

  • Correlate with electron microscopy findings showing outer dynein arm defects

• Molecular phenotyping:

  • Use ODAD4 antibodies alongside antibodies against other PCD-associated proteins

  • Establish protein expression profiles for different genetic subtypes of PCD

  • Develop immunofluorescence panels for classification of PCD subtypes

• Functional studies:

  • Combine ODAD4 immunostaining with high-speed video microscopy to correlate protein localization with ciliary beat patterns

  • Assess ciliary function in response to genetic manipulation of ODAD4

This approach is particularly valuable given the high incidence of PCD (approximately 1:7,500) and the growing recognition that many cases remain undiagnosed or misdiagnosed.

What methodological approaches enable the study of ODAD4 post-translational modifications?

Investigating post-translational modifications (PTMs) of ODAD4 requires specialized antibody-based techniques:

• Phosphorylation studies:

  • Use phospho-specific antibodies (when available)

  • Combine with phosphatase treatment as a control

  • Perform 2D gel electrophoresis followed by Western blotting to separate phosphorylated isoforms

• Ubiquitination analysis:

  • Immunoprecipitate ODAD4 under denaturing conditions

  • Probe with anti-ubiquitin antibodies

  • Use proteasome inhibitors (MG132, 10 μM for 4-6 hours) to accumulate ubiquitinated forms

• Other modifications:

  • For acetylation studies: Treat cells with deacetylase inhibitors before analysis

  • For glycosylation: Use enzymatic deglycosylation (PNGase F) followed by Western blot

These approaches can reveal regulatory mechanisms controlling ODAD4 function in both normal and disease states, potentially identifying novel therapeutic targets for ciliopathies.

How can ODAD4 antibodies be employed in super-resolution microscopy studies?

Super-resolution microscopy techniques offer unprecedented insights into ciliary ultrastructure and can be optimized for ODAD4 visualization:

• Fluorophore selection:

  • For STED microscopy: Use antibodies conjugated to STED-compatible fluorophores (STAR 580, STAR RED)

  • For STORM/PALM: Consider using antibodies with photoswitchable fluorophores

• Sample preparation:

  • Use thinner sections (70-100 nm) for 3D-SIM

  • Optimize fixation to preserve antigenicity while minimizing autofluorescence

  • Consider expansion microscopy protocols to physically expand ciliary structures

• Co-localization studies:

  • Combine ODAD4 antibodies with antibodies against other axonemal components

  • Use appropriate controls to confirm doublet localization patterns

  • Implement quantitative co-localization analysis using specialized software

This approach can resolve the precise positioning of ODAD4 within the 96 nm repeat pattern of the ciliary axoneme, providing structural insights beyond conventional microscopy capabilities.

What are the methodological considerations for using ODAD4 antibodies in high-throughput screening?

Adapting ODAD4 antibodies for high-throughput screening applications requires several methodological optimizations:

• Assay miniaturization:

  • Develop 384-well or 1536-well compatible immunofluorescence protocols

  • Optimize cell seeding density and antibody concentrations for signal consistency

  • Consider automated liquid handling systems for reproducible results

• Readout methods:

  • Implement high-content imaging with automated ciliary detection algorithms

  • Develop quantitative measurements of ODAD4 localization and intensity

  • Consider reporter systems where ODAD4 function is linked to a measurable output

• Validation strategies:

  • Include positive controls (known ciliary assembly disruptors)

  • Use siRNA against ODAD4 as a negative control

  • Implement robust statistical analysis methods to identify true hits

This approach enables screening for compounds that affect ODAD4 localization or function, potentially identifying therapeutic candidates for ciliopathies. The insights gained from such screens can also reveal novel regulatory mechanisms controlling ODAD4 activity.

How can researchers address common technical challenges with ODAD4 antibodies?

When working with ODAD4 antibodies, researchers may encounter several technical challenges that can be addressed through methodological adjustments:

• Weak or absent signal in Western blot:

  • Increase protein loading (50-75 μg)

  • Extend primary antibody incubation (overnight at 4°C)

  • Use signal enhancement systems (e.g., biotin-streptavidin amplification)

  • Consider more sensitive detection methods (chemiluminescence substrate optimization)

• High background in immunofluorescence:

  • Extend blocking time (2-3 hours at room temperature)

  • Use specialized blocking reagents (Image-iT FX, mouse-on-mouse blocking kit for mouse monoclonals)

  • Implement additional washing steps (5× 5 minutes with 0.1% Tween-20)

  • Optimize antibody concentration through titration experiments

• Cross-reactivity issues:

  • Pre-absorb antibody with tissue lysates from species with low homology

  • Use monoclonal antibodies targeting unique epitopes

  • Implement more stringent washing conditions (higher salt concentration)

These approaches can significantly improve experimental outcomes when working with ODAD4 antibodies across different applications.

What are the optimal approaches for detecting ODAD4 in different species?

When conducting cross-species ODAD4 studies, consider the following methodological adaptations:

• Species selection:

  • Human, mouse, and rat samples typically work well with available antibodies

  • For other species, conduct epitope conservation analysis using sequence alignment tools

• Antibody selection strategy:

  • For highly conserved regions: Use antibodies targeting evolutionarily conserved domains

  • For species-specific studies: Choose antibodies raised against species-specific epitopes

  • Consider using multiple antibodies targeting different regions to confirm results

• Protocol modifications:

  • Adjust antibody concentration for different species (typically higher for less conserved targets)

  • Modify incubation times (longer for less conserved targets)

  • Adapt epitope retrieval conditions based on tissue fixation methods

By implementing these approaches, researchers can conduct meaningful comparative studies across species, providing evolutionary insights into ODAD4 function and conservation.